Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

Inclusion Criteria: * Patients of both sexes with age \> 60 years and newly diagnosed acute myeloid leukaemia as defined by new WHO classification * written informed consent Exclusion Criteria: * pretreatment of leukemia * no informed consent * simultaneous inclusion in other studies * mental disability * contraindication for intensive chemotherapy * AML FAB M3 * contraindication for allogeneic stem cell transplantation * restriction of following organ functions: * creatinine-clearance \< 50 ml/min * cardiac ejection fraction \< 40 % * severe pulmonary restriction * bilirubin \> 2x ULN; SGOT and SGPT \> 4x ULN * uncontrolled hypertension * severe uncontrolled metabolism disturbance * Karnofsky-performance-score \< 70% * hepatitis C * other malignancy * age of unrelated donor \>70 years and age of related donor \>75 years